Melatonin interactions with blood pressure and vascular function during l-NAME-induced hypertension

Journal of Pineal Research

Volumn 48, Issue 2, 2010, Pages 102-108

  Paulis, Ludovit ^a,b,c   Pechanova, Olga ^c,d   Zicha, Josef ^d   Barta, Andrej ^c   Gardlik, Roman ^b   Celec, Peter ^b   Kunes, Jaroslav ^d   Simko, Fedor ^a,b  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b Physics and Informatics   (Slovakia)

^c INSTITUTE OF CHEMISTRY   (Slovakia)

^d INSTITUTE OF MATHEMATICS   (Czech Republic)

Author keywords

Endothelium derived constricting factor; Femoral artery; Hypertension; Melatonin; Mesenteric artery; N nitro l arginine methyl ester; Nitric oxide; Vessel myograph

Indexed keywords

ACETYLCHOLINE; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; INDOLEAMINE; MELATONIN; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE;

AORTA; ARTERY DIAMETER; ARTICLE; BLOOD PRESSURE; BLOOD VESSEL DIAMETER; BLOOD VESSEL REACTIVITY; CAROTID ARTERY; DIASTOLIC BLOOD PRESSURE; ENZYME ACTIVITY; FEMORAL ARTERY; GENE EXPRESSION; HEMODYNAMICS; HYPERTENSION; MALE; MESENTERIC ARTERY; NONHUMAN; RAT; SYSTOLIC BLOOD PRESSURE; VASOCONSTRICTION; WISTAR RAT;

ACETYLCHOLINE; ANIMALS; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; CYCLOOXYGENASE 2; ENDOTHELINS; HYPERTENSION; MALE; MELATONIN; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE; RATS; RATS, WISTAR; VASODILATION;

EID: 75149190378     PISSN: 07423098     EISSN: 1600079X     Source Type: Journal    
DOI: 10.1111/j.1600-079X.2009.00732.x     Document Type: Article

References (43)

1. Redwood SR. Hypertension, society, and public policy. Eur Heart J Suppl 2007 9 : B13 B18.
2. Kawashima K, Miwa Y, Fujimoto K, et al. Antihypertensive action of melatonin in the spontaneously hypertensive rat. Clin Exp Hypertens A 1987 9 : 1121 1131.
3. Scheer FA, Van Montfrans GA, van Someren EJ, et al. Daily nighttime melatonin reduces blood pressure in male patients with essential hypertension. Hypertension 2004 43 : 192 197.
4. Erşahin M, Sehirli O, Toklu HZ, et al. Melatonin improves cardiovascular function and ameliorates renal, cardiac and cerebral damage in rats with renovascular hypertension. J Pineal Res 2009 47 : 97 106.
5. Tengattini S, Reiter RJ, Tan DX, et al. Cardiovascular diseases: protective effects of melatonin. J Pineal Res 2008 44 : 16 25.
6. Chen Z, Chua CC, Gao J, et al. Prevention of ischemia/reperfusion-induced cardiac apoptosis and injury by melatonin is independent of glutathione peroxdiase 1. J Pineal Res 2009 46 : 235 241.
7. Veneroso C, Tuñón MJ, González-Gallego J, et al. Melatonin reduces cardiac inflammatory injury induced by acute exercise. J Pineal Res 2009 47 : 184 191.
8. Simko F, Paulis L. Melatonin as a potential antihypertensive treatment. J Pineal Res 2007 42 : 319 322.
9. Reiter RJ, Korkmaz A. Clinical aspects of melatonin, Saudi Med J 2008 29 : 1537 1547.
10. Reiter RJ, Tan DX, Korkmaz A. The circadian melatonin rhythm and its modulation: possible impact on hypertension. J Hypertens 2009 27 (Suppl. 6 S17 S20.
11. Simko F, Pechanova O. Potential roles of melatonin and chronotherapy among the new trends in hypertension treatment. J Pineal Res 2009 47 : 127 133.
12. Paulis L, Simko F. Blood pressure modulation and cardiovascular protection by melatonin: Potential mechanisms behind. Physiol Res 2007 56 : 671 684.
13. Simko F, Pechanova O. Recent trends in hypertension treatment: perspectives from animal studies. J Hypertens 2009 27 (Suppl. 6 S1 S4.
14. Reiter RJ, Paredes SD, Manchester LC, et al. Reducing oxidative/nitrosative stress: a newly-discovered genre for melatonin. Crit Rev Biochem Mol Biol 2009 44 : 175 200.
15. Paulis L, Zicha J, Kunes J, et al. Regression of L-NAME-induced hypertension: the role of nitric oxide and endothelium-derived constricting factor. Hypertens Res 2008 31 : 793 803.
16. Kogure K, Watson BD, Busto R, et al. Potentiation of lipid peroxides by ischemia in rat brain. Neurochem Res 1982 7 : 437 454.
17. Bredt DS, Snyder SH. Isolation of nitric oxide synthetase, a calmodulin-requiring enzyme. Proc Natl Acad Sci USA 1990 87 : 682 685.
18. Mulvany MJ, Halpern W. Contractile properties of small arterial resistance vessels in spontaneously hypertensive and normotensive rats. Circ Res 1977 41 : 19 26.
19. Ribeiro MO, Antunes E, de-Nucci G, et al. Chronic inhibition of nitric oxide synthesis. A new model of arterial hypertension. Hypertension 1992 20 : 298 303.
20. Pechanova O, Bernatova I, Pelouch V, et al. Protein remodeling of the heart in NO deficient hypertension: The effect of captopril. J Mol Cell Cardiol 1997 29 : 3365 3374.
21. Simko F, Simko J. The potential role of nitric oxide in the hypertrophic growth of the left ventricle. Physiol Res 2000 49 : 37 46.
22. Simko F, Luptak I, Matuskova J, et al. L-arginine fails to protect against myocardial remodelling in L-NAME-induced hypertension. Eur J Clin Invest 2005 35 : 362 368.
23. Simko F, Matuskova J, Luptak I, et al. Effect of simvastatin on remodeling of the left ventricle and aorta in L-NAME-induced hypertension. Life Sci 2004 74 : 1211 1224.
24. Rossi MA, Colombini-Netto M. Chronic inhibition of NO synthesis per se promotes structural intimal remodeling of the rat aorta. J Hypertens 2001 19 : 1567 1579.
25. Simko F, Pechanova O, Pelouch V, et al. Effect of melatonin, captopril, spironolactone and simvastatin on blood pressure and left ventricular remodeling in spontaneously hypertensive rats. J Hypertens 2009 27 (Suppl. 6 S5 S10.
26. Paulis L, Pechanova O, Zicha J, et al. Melatonin prevents fibrosis but not hypertrophy development in the left ventricle of L-NAME hypertensive rats. J Hypertens 2009 27 (Suppl. 6 S11 S16.
27. Grossman E, Laudon M, Yalcin R, et al. Melatonin reduces night blood pressure in patients with nocturnal hypertension. Am J Med 2006 119 : 898 902.
28. Pechanova O, Zicha J, Paulis L, et al. The effect of N-acetylcysteine and melatonin in adult spontaneously hypertensive rats with established hypertension. Eur J Pharmacol 2007 561 : 129 136.
29. Nava M, Quiroz Y, Vaziri N, et al. Melatonin reduces renal interstitial inflammation and improves hypertension in spontaneously hypertensive rats. Am J Physiol Renal Physiol 2003 284 : F447 F454.
30. Tan DX, Manchester LC, Terron MP, et al. One molecule, many derivatives: a never-ending interaction of melatonin with reactive oxygen and nitrogen species? J Pineal Res 2007 42 : 28 42.
31. Korkmaz A, Reiter RJ, Topal T, et al. Melatonin: an established antioxidant worthy of use in clinical trials. Mol Med 2009 15 : 43 50.
32. Hardeland R, Tan DX, Reiter RJ. Kynuramines, metabolites of melatonin and other indoles: the resurrection of an almost forgotten class of biogenic amines. J Pineal Res 2009 47 : 109 126.
33. Gitto E, Pellegrino S, Gitto P, et al. Oxidative stress of the newborn in the pre- and postnatal period and the clinical utility of melatonin. J Pineal Res 2009 46 : 128 139.
34. Hung MW, Tipoe GL, Poon AM, et al. Protective effect of melatonin against hippocampal injury of rats with intermittent hypoxia. J Pineal Res 2008 44 : 214 221.
35. 1-acetyl-5-methoxykynuramine (AMK), in macrophages. J Neuroimmunol 2005 165 : 139 149.
36. León J, Escames G, Rodríguez MI, et al., Acuña-Castroviejo D Inhibition of neuronal nitric oxide synthase activity by N1-acetyl-5-methoxykynuramine, a brain metabolite of melatonin. J Neurochem 2006 98 : 2023 2033.
37. Kanner J, Harel S, Granit R. Nitric oxide, an inhibitor of lipid oxidation by lipoxygenase, cyclooxygenase and hemoglobin. Lipids 1992 27 : 46 49.
38. Vanhoutte PM, Shimokawa H, et al. Endothelial dysfunction and vascular disease. Acta Physiol 2009 196 : 193 222.
39. Paulis L, Simko F. LA419, a novel nitric oxide donor, prevents cardiac remodeling via the endothelial nitric oxide synthase pathway: NO donors as a means of antiremodeling. Hypertension 2009 50 : 1009 1011.
40. Paulis L, Matuskova J, Adamcova M, et al. Regression of left ventricular hypertrophy and aortic remodelling in NO-deficient hypertensive rats: effect of L-arginine and spironolactone. Acta Physiol (Oxf) 2008 194 : 45 55.
41. Torok J, Babal P, Matuskova J, et al. Impaired endothelial function of thoracic aorta in hereditary hypertriglyceridemic rats. Ann NY Acad Sci 2002 967 : 469 475.
42. Simko F, Luptak I, Matuskova J, et al. Heart remodeling in the hereditary hypertriglyceridemic rat: effect of captopril and nitric oxide deficiency. Ann N Y Acad Sci 2002 967 : 454 462.
43. G-nitro-l-arginine in rats. Am J Physiol 1992 263 : H1090 H1094.